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Agouti-related 
peptide in uremic 
cachexia
Muscle wasting, common in uremia, 
may be due to the imbalance between 
insulin-like growth factor (IGF)-I, which 
increases muscle mass, and myostatin, 
which inhibits its development. Agouti-
related peptide, a melanocortin-4 
receptor antagonist, has been shown to 
reduce uremic cachexia. Thus, in previ-
ous studies, Cheung and his co-workers 
had proposed that a central mechanism 
involving leptin and melanocortin signal-
ing is critical for the pathogenesis of ure-
mic cachexia. As they report in this issue, 
the same group found that injection of 
agouti-related peptide into cerebral ven-
tricles caused a gain of body mass in a 
mouse model of uremic cachexia. These 
salutary effects occurred regardless of 
increased protein and calorie intake. 
The skeletal muscles of uremic mice had 
increased myostatin mRNA and protein 
and decreased IGF-I concentrations; 
the presence of agouti-related peptide 
improved these concentrations, bringing 
the balance of myostatin and IGF closer 
to the normal range. See page 180.
Caregiving in ESRD
End-stage renal disease (ESRD) affects 
families as well as individual patients. The 
burden on spouses, friends, and other 
caregivers needs to be assessed when a 
comprehensive treatment plan for the 
patient is formulated. Horsburgh et al. 
systematically measured this burden by 
developing a questionnaire that estimates 
the two types of duties of caregivers. The 
cognitive work included appraisal, advo-
cating, juggling, and creating a routine for 
the patients. The concrete tasks included 
providing transportation, performing 
dialysis, personal hygiene, diet, symp-
tom relief, comfort measures, and teach-
ing self-care. The reliability and validity of 
these evaluations were studied in a large 
sample of Canadian family members. The 
validity of the questionnaire showed posi-
tive correlations between the caregivers, 
their perceived burden, conscientious-
ness, and self-care abilities. These meth-
ods should be applicable to all family 
members of patients with ESRD and offer 
a more realistic evaluation of the burden 
of caregiving. See page 230.
Vitamin D and 
cardiovascular 
function
A number of epidemiological studies 
suggest that calcium and phosphate levels 
correlate with cardiovascular mortality. 
But the system that regulates these two 
levels is intimately related to vitamin D, 
a hormone whose receptor is a transcrip-
tion factor that exerts a large number 
of known and unknown target genes. 
As they report in this issue, Zhou et al. 
studied mice with a deletion of 25(OH)D 
1α-hydroxylase, the enzyme that gener-
ates active vitamin D. The mutant mice 
were fed different diets, one of which 
corrects the anomalies in serum calcium 
and phosphate. The authors found that 
the knockout mice developed hyperten-
sion, cardiac hypertrophy, and impaired 
cardiac function along with an upregula-
tion of the renin–angiotensin system in 
both renal and cardiac tissues. When the 
mice were fed a diet that corrected their 
serum calcium and phosphate levels, 
the anomalies in blood pressure, cardiac 
structure–function, and the renin–
angiotensin system remained. However, 
treatment of the mutant mice with the 
active hormone 1,25(OH)2D3 not only 
normalized serum calcium and phos-
phorus levels but also normalized blood 
pressure, cardiac structure–function, 
and the renin–angiotensin system. 
These studies emphasize the critical role 
that vitamin D plays in cardiac function. 
See page 170.
